Drawing for GA-EPO

USPTO serial 75775785

GA-EPO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SUAREZ, MARIA VICTORIA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GA-EPO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy H. Hiebert

TIMOTHY H HIEBERT SAMUELS, GAUTHIER & STEVENS LLP225 FRANKLIN ST STE 3300BOSTON, MA 02110UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Product research and development services for others in the field of pharmaceuticals and biologics; consulting services in the field of pharmaceutical and biologic production methods, and in the field of clinical protocols for pharmaceuticals and biologics; scientific research services; health care services; diagnostic and genetic medical testing services; medical patient monitoring services; providing information to others about pharmaceuticals, biologics and health care; intellectual property licensing services in the field of pharmaceuticals and biologicsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 23, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 27, 2003EX5GSOU EXTENSION 5 GRANTED—
Dec 26, 2002EXT5SOU EXTENSION 5 FILED—
Dec 26, 2002EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 10, 2002EX4GSOU EXTENSION 4 GRANTED—
Jul 1, 2002EXT4SOU EXTENSION 4 FILED—
Jul 1, 2002EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2002EX3GSOU EXTENSION 3 GRANTED—
Jan 7, 2002EXT3SOU EXTENSION 3 FILED—
Jul 25, 2001EX2GSOU EXTENSION 2 GRANTED—
Jul 11, 2001EXT2SOU EXTENSION 2 FILED—
Jan 28, 2001EX1GSOU EXTENSION 1 GRANTED—
Nov 20, 2000EXT1SOU EXTENSION 1 FILED—
Jul 11, 2000NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 18, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2000NPUBNOTICE OF PUBLICATION—
Dec 16, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 1, 1999DOCKASSIGNED TO EXAMINER—
Nov 19, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance